FdaApplication
ANDA 071730
Identifiers
- fda_app_no: ANDA071730
Properties
| Property | Value |
|---|---|
| applicant_name | QUANTUM PHARMICS LTD |
| application_type | ANDA |
| approval_date | 1987-10-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CLORAZEPATE DIPOTASSIUM | CLORAZEPATE DIPOTASSIUM | 3.75MG | TABLET;ORAL |
1 product